Skip to Main Content

Author Details

Fr??d??rique Deshayes
Universite Paris Cite, CNRS
2002
29
18
Antoine Forget (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
35875939Interplay between EGFR, E-cadherin, and PTP1B in epidermal homeostasis.Tissue Barriers2023
35256668Link between the EZH2 noncanonical pathway and microtubule organization center polarization during early T lymphopoiesis.Sci Rep2022
35809481Cisplatin causes covalent inhibition of protein-tyrosine phosphatase 1B (PTP1B) through reaction with its active site cysteine: Molecular, cellular and in vivo mice studies.Biomed Pharmacother2022
35806064Biochemical, Enzymatic, and Computational Characterization of Recurrent Somatic Mutations of the Human Protein Tyrosine Phosphatase PTP1B in Primary Mediastinal B Cell Lymphoma.Int J Mol Sci2022
34811416Identification of a new regulation pathway of EGFR and E-cadherin dynamics.Sci Rep2021
29213102E-cadherin dynamics is regulated by galectin-7 at epithelial cell surface.Sci Rep2017
28166391Lactosamine-Based Derivatives as Tools to Delineate the Biological Functions of Galectins: Application to Skin Tissue Repair.Chembiochem2017
29257082Galectin-7 in Epithelial Homeostasis and Carcinomas.Int J Mol Sci2017
29024281Development of a Sensitive Microarray Platform for the Ranking of Galectin Inhibitors: Identification of a Selective Galectin-3 Inhibitor.Chembiochem2017
26995087The Parkinsonism-associated protein DJ-1/Park7 prevents glycation damage in human keratinocyte.Biochem Biophys Res Commun2016
25741714Overexpression of galectin-7 in mouse epidermis leads to loss of cell junctions and defective skin repair.PLoS One2015
26059300[Galectins, a class of unconventional lectins].Med Sci (Paris)2015
25097826Galectins in epithelial functions.Tissue Barriers2014
23221682Generation and characterization of rendomab-B1, a monoclonal antibody displaying potent and specific antagonism of the human endothelin B receptor.MAbs2013
22406932Nanog and Oct4 overexpression increases motility and transmigration of melanoma cells.J Cancer Res Clin Oncol2012
23039186LFA-1 and ICAM-1 expression induced during melanoma-endothelial cell co-culture favors the transendothelial migration of melanoma cell lines in vitro.BMC Cancer2012
22454190Plasticity of melanoma cells induced by neural cell crest conditions and three-dimensional growth.Melanoma Res2012
22536420Angiotensin II facilitates breast cancer cell migration and metastasis.PLoS One2012
22487681PHF19 and Akt control the switch between proliferative and invasive states in melanoma.Cell Cycle2012
21466663Junctional adhesion molecules are required for melanoma cell lines transendothelial migration in vitro.Pigment Cell Melanoma Res2011
21688998Electroporation-aided DNA immunization generates polyclonal antibodies against the native conformation of human endothelin B receptor.DNA Cell Biol2011
19574933Coexpression of major histocompatibility complex class II with chemokines and nuclear NFkappaB p50 in melanoma: a rational for their association with poor prognosis.Melanoma Res2009
18172003BAFF enhances chemotaxis of primary human B cells: a particular synergy between BAFF and CXCL13 on memory B cells.Blood2008
17304627Pathologic expression of MHC class II is driven by mitogen-activated protein kinases.Eur J Immunol2007
16597412[Endothelin-1, angiotensin II and cancer].Med Sci (Paris)2006
16887298Structural organization and expression of human MTUS1, a candidate 8p22 tumor suppressor gene encoding a family of angiotensin II AT2 receptor-interacting proteins, ATIP.Gene2006
16061390Angiotensin receptors: a new role in cancer?Trends Endocrinol Metab2005
14691452Abnormal production of the TNF-homologue APRIL increases the proliferation of human malignant glioblastoma cell lines via a specific receptor.Oncogene2004
11960555Natural antisense RNA inhibits the expression of BCMA, a tumour necrosis factor receptor homologue.BMC Mol Biol2002
  • 1 - 29 of 29

Recommended Authors

The Hospital for Sick Children
Career Start Year 2014
Number of shared co-authors 1
Institut National de la Sante et de la Recherche Medicale (INSERM) U
Career Start Year 2010
Number of shared co-authors 0
Center for Cancer Research, National Cancer Institute
Career Start Year 2008
Number of shared co-authors 0
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Career Start Year 2007
Number of shared co-authors 0
Uppsala University
Career Start Year 2004
Number of shared co-authors 0
Institute of Anatomy, Technische Universitat Dresden School of Medicine
Career Start Year 2001
Number of shared co-authors 0
Aier Eye Hospital of Wuhan University
Career Start Year 2001
Number of shared co-authors 0
Cancer Stem Cell Research Center, Samsung Biomedical Research Institute
Career Start Year 2001
Number of shared co-authors 0
INSERM U1021, Institut Curie, PSL Research University, Campus Universitaire
Career Start Year 1999
Number of shared co-authors 0
Henan-Macquarie University Joint Centre for Biomedical Innovation, Henan University
Career Start Year 1997
Number of shared co-authors 0
Candiolo Cancer Institute - FPO IRCCS
Career Start Year 1993
Number of shared co-authors 0
Oncode Institute
Career Start Year 1993
Number of shared co-authors 1
Sidney Kimmel Cancer Center, Johns Hopkins School of Medicine
Career Start Year 1992
Number of shared co-authors 0
Yale School of Medicine
Career Start Year 1992
Number of shared co-authors 0
College of Medicine, University of Saskatchewan
Career Start Year 1992
Number of shared co-authors 0
Uppsala University
Career Start Year 1991
Number of shared co-authors 0
Center for Cancer Research, National Cancer Institute
Career Start Year 1990
Number of shared co-authors 0
Amsterdam University Medical Center
Career Start Year 1989
Number of shared co-authors 0
Instituto do Cancer do Estado de Sao Paulo, Faculdade de Medicina de Sao Paulo
Career Start Year 1989
Number of shared co-authors 0
Candiolo Cancer Institute, Fondazione del Piemonte per l'Oncologia (FPO) - IRCCS
Career Start Year 1988
Number of shared co-authors 0
Rutgers New Jersey Medical School
Career Start Year 1987
Number of shared co-authors 1
Institut Curie, PSL Research University, INSERM U1021
Career Start Year 1987
Number of shared co-authors 0
Institute of Pharmaceutical Sciences, ETH Zurich
Career Start Year 1986
Number of shared co-authors 0
Institute for Research in Immunology and Cancer (IRIC), University of Montreal
Career Start Year 1986
Number of shared co-authors 0
Moores Cancer Center, University of California San Diego
Career Start Year 1984
Number of shared co-authors 0
Louisiana State University Health Sciences Center
Career Start Year 1983
Number of shared co-authors 0
Universite de Paris-Cite
Career Start Year 1979
Number of shared co-authors 1
Wihuri Research Institute
Career Start Year 1977
Number of shared co-authors 0
The University of Texas MD Anderson Cancer Center
Career Start Year 1975
Number of shared co-authors 1
Ellen and Ronald Caplan Cancer Center, The Wistar Institute
Career Start Year 1972
Number of shared co-authors 0

Collaborators

Institute of Bioengineering, Miguel Hernandez University of Elche
Co-authored papers 7
INSERM UMRS, University Paris Cite
Co-authored papers 3
Universite de Paris, Sorbonne Universite, Inserm U8, Institut Universitaire de France
Co-authored papers 3
Universite Paris Cite, CNRS
Co-authored papers 2
Universite de Strasbourg
Co-authored papers 2
Groupe Hospitalier Universitaire Paris Psychiatrie et Neurosciences
Co-authored papers 2
Universite de Paris, CNRS
Co-authored papers 2
INSERM UMR-S1124, Universite Paris Cite
Co-authored papers 2
University of California San Francisco
Co-authored papers 1
CHU de Quebec Research Center
Co-authored papers 1
INSERM U
Co-authored papers 1
Nencki Institute of Experimental Biology
Co-authored papers 1
Shandong Jianzhu University
Co-authored papers 1